Comprehensive Report: Cannabinoids Use by Patients in Cancer Treatment
VerifiedAdded on  2023/01/13
|6
|871
|90
Report
AI Summary
This report delves into the use of cannabinoids by cancer patients, addressing how they are utilized, supported by research, and the potential side effects associated with concurrent use with oncology medications. The report begins with an executive summary, followed by an introduction defining cannabinoids and their application in treating cancer-related symptoms such as pain, inflammation, and anxiety. The main body details various methods of cannabinoid administration, including smoking, inhalation, topical application, and sublingual drops, emphasizing the importance of medical consultation. It then presents a study supporting the use of Cannabis sativa, highlighting its antitumour properties and role in managing cancer symptoms. The report also discusses potential side effects, such as depression, hallucination, dizziness, and low blood pressure, associated with excessive cannabinoid use, particularly in conjunction with oncology medications like Abraxane, Cytoxan, and Doxil. The conclusion summarizes the key findings, reiterating the therapeutic potential of cannabinoids while cautioning against overuse. The report is supported by references to academic journals and online resources.
Contribute Materials
Your contribution can guide someone’s learning journey. Share your
documents today.
1 out of 6